These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6614962)

  • 41. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
    Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
    Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
    Brockmeyer NH; Frühauf S; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1998 Aug; 3(8):361-6. PubMed ID: 9707517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple assays of retinoid activity as potential screens for compounds that may be useful in treatment of psoriasis.
    West MR; Page JM; Turner DM; Wood EJ; Holland DB; Cunliffe WJ; Rupniak HT
    J Invest Dermatol; 1992 Jul; 99(1):95-100. PubMed ID: 1376755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
    Nijsten TE; Stern RS
    J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Action of a new synthetic ACTH drug in psoriatic arthropathy].
    Hundeiker M
    Z Hautkr; 1976 Aug; 51(16):663-8. PubMed ID: 184614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experience with the treatment of psoriatic arthritis using tigazon].
    Shakhtmeĭster IIa; Pokryshkin VI; Pisarenko MF; Shakhtmeĭster SI
    Vestn Dermatol Venerol; 1986; (2):37-9. PubMed ID: 3705734
    [No Abstract]   [Full Text] [Related]  

  • 53. [Epidermic chalone receptors in psoriasis treated with retinoid:Ro 10-9359].
    Vignale RA; Lasalvia E; Espasandín J; Borras A
    Med Cutan Ibero Lat Am; 1983; 11(4):241-6. PubMed ID: 6314070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents.
    Kneissel M; Studer A; Cortesi R; Susa M
    Bone; 2005 Feb; 36(2):202-14. PubMed ID: 15780946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arotinoid-ethylester. Effectiveness in refractory cutaneous T-cell lymphoma.
    Hoting E; Meissner K
    Cancer; 1988 Sep; 62(6):1044-8. PubMed ID: 3409182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The treatment of psoriasis-arthritis with cyclosporin A, a new immunosuppressive agent].
    Müller W; Graf U
    Schweiz Med Wochenschr; 1981 Mar; 111(12):408-13. PubMed ID: 7221517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 58. Reiter's disease: successful treatment of the skin manifestations with oral etretinate.
    Benoldi D; Alinovi A; Bianchi G; Buticchi G
    Acta Derm Venereol; 1984; 64(4):352-4. PubMed ID: 6209899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
    Sarnoff DS; Saini R
    J Drugs Dermatol; 2008 May; 7(5):475-8. PubMed ID: 18505142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.